Financials in USD. Standardized financial statements.
A compact view of how Alaunos Therapeutics, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $5,000 | $10,000 | $5,000 | $2.92M | $398,000 | $0 | $0 | $146,000 | $6.39M | $6.86M |
| Revenue Growth? | -50.0% | +100.0% | -99.8% | +634.2% | 0.0% | 0.0% | -100.0% | -97.7% | -6.9% | 0.0% |
| Cost of Revenue? | $0 | $0 | $4.80M | $0 | $0 | $1.13M | $629,000 | $0 | $0 | $0 |
| Gross Profit? | $5,000 | $10,000 | -$4.80M | $2.92M | $398,000 | -$1.13M | -$629,000 | $146,000 | $6.39M | $6.86M |
| Gross Margin? | +100.0% | +100.0% | -95960.0% | +100.0% | +100.0% | 0.0% | 0.0% | +100.0% | +100.0% | +100.0% |
| Operating Expenses? | $4.23M | $4.82M | $29.47M | $38.03M | $77.95M | $79.23M | $57.23M | $54.05M | $59.88M | $172.17M |
| Operating Income? | -$4.22M | -$4.81M | -$34.27M | -$35.10M | -$77.55M | -$80.36M | -$57.86M | -$53.91M | -$53.49M | -$165.31M |
| EBITDA? | -$4.22M | -$4.68M | -$30.90M | -$31.82M | -$74.97M | -$78.85M | -$117.17M | -$53.33M | -$53.12M | -$165.01M |
| Income Before Tax | -$4.18M | -$4.68M | -$35.14M | -$37.73M | -$78.75M | -$79.98M | -$117.80M | -$53.12M | -$54.32M | -$165.30M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $114,000 |
| Net Income? | -$4.18M | -$4.68M | -$35.14M | -$37.73M | -$78.75M | -$79.98M | -$117.80M | -$53.12M | -$54.32M | -$165.30M |
| EPS? | $-2.20 | $-2.92 | $-21.97 | $-25.97 | $-53.80 | $-56.42 | $-158.90 | $-55.52 | $-59.50 | $-190.15 |
| Diluted EPS? | $-2.20 | $-2.92 | $-21.97 | $-25.97 | $-53.80 | $-56.42 | $-158.90 | $-55.44 | $-59.50 | $-190.15 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality